News from all angles
(MedPage Today) -- Mirodenafil (known as AR1001), an oral phosphodiesterase-5 inhibitor approved in South Korea to treat erectile dysfunction, showed mixed results in people with early Alzheimer's di…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network